Therapeutic monoclonal antibodies are among the most promising new clinical options, treating a variety of different ailments.
Clinical use of monoclonal antibodies like bevacizumab, rituximab, and adalimumab has increased dramatically in recent years, and has spurred increased primary research into these promising new treatments.
The ability to precisely quantify serum levels of therapeutic mAbs is of the utmost importance for researchers who would like to further characterize these drugs, and identify new safe and effective uses for them.
To support this research, antibodies-online has partnered with AffinityImmuno, a Canadian solutions provider who produces kits for quantitative analysis of more than a dozen different therapeutic mAbs.
Check out all of the AffinityImmuno kits at antibodies-online, or see kits specifically for: